Doxercalciferol is a medication used to treat secondary hyperparathyroidism and metabolic bone disease. It inhibits the synthesis and secretion of parathyroid hormone. The drug was developed by Bristol-Myers Squibb under the brand name Hectorol. Doxercalciferol is a synthetic vitamin D2 analog that undergoes metabolic activation in vitro to form 1?, 25-dihydroxy vitamin D2. It is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis. Doxercalciferol is a man-made form of vitamin D. It works by decreasing PTH levels and increasing calcium/phosphorus levels in the body. People with kidney disease who have high levels of PTH may need more of this medication.
MARKET SCOPE
The Doxercalciferol Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Doxercalciferol Market with detailed market segmentation by type, material, end-user, and geography. The report provides key statistics on the market status of the leading Doxercalciferol Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the Doxercalciferol Market is segmented into Injection and Capsule.
- By Application, the Doxercalciferol Market is segmented into SHPT in patients with CKD on dialysis, SHPT in patients with stage 3 or stage 4 CKD
MARKET DYNAMICS
Drivers:
- Increased demand for high-quality industrial valves in the Pharmaceuticals, Healthcare, and other industries.
- Adoption of Artificial Intelligence (AI) by pharma and biotech.
- Expanding chemical space for drug discovery explorations.
- Lack of awareness and limited healthcare services in developing regions.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Doxercalciferol Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Doxercalciferol Market in these regions.
IMPACT OF COVID-19 ON DOXERCALCIFEROL MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic. The market ecosystem has taken a directional shift in the way the supply-side of the market is accessed. The demand for Vitamin-D supplements surged during the coronavirus pandemic, primarily due to the bulk buying behavior of consumers. Bulk purchases are not merely a lockdown-induced trend but are expected to stay throughout 2020. Consumers are trying to reduce the number of store visits as a part of social distancing.
MARKET PLAYERS
The report covers key developments in the Doxercalciferol Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market players from the Doxercalciferol Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Doxercalciferol Market in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Doxercalciferol Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Prasco Laboratories
- Hikma Pharmaceuticals
- Amneal Pharms
- Pfizer
- Akorn
- West-Ward Pharmaceuticals
- Sanofi
- Bio-Tech Pharma
- Synthesia
- PHW Group